Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers
Abstract: Introduction: The expression of T-cell-associated antigens on diffuse large B-cell lymphoma (DLBCL) is uncommon. The coexpression of ≥2 T-cell-associated antigens on DLBCL is even rarer. This has been reported in the literature only a few times, most commonly coexpression of either CD5 or CD8 and a second, different T-cell marker. Case Presentation: This case report features a patient who presented with a rapidly evolving head and neck mass that displayed coexpression of CD5 and CD8. Conclusion: In this case report, we present the first case to our knowledge of DLBCL with coexpression of only CD5 and CD8.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers ; volume:17 ; number:1 ; year:2024 ; pages:517-523 ; extent:7
Case reports in oncology ; 17, Heft 1 (2024), 517-523 (gesamt 7)
- Urheber
-
Fan, Janet
Thanedar, Sarita
Ovechko, Vasily
Jana, Bagi
- DOI
-
10.1159/000536571
- URN
-
urn:nbn:de:101:1-2406270105010.442249802336
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fan, Janet
- Thanedar, Sarita
- Ovechko, Vasily
- Jana, Bagi
Ähnliche Objekte (12)
Aberrant cell cycle regulatory ubiquitin networks in B-cell malignancies
Aberrant B-Cell Activation in Systemic Lupus Erythematosus
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
Mouse models for aberrant NF-kB activation in B-cell development and lymphomagenesis
The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles
Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Single-cell Co-expression Subnetwork Analysis
IGFBP 1 increases β‐cell regeneration by promoting α‐ to β‐cell transdifferentiation
Aberrant cell cycle regulatory ubiquitin networks in B-cell malignancies
Aberrant B-Cell Activation in Systemic Lupus Erythematosus
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
Mouse models for aberrant NF-kB activation in B-cell development and lymphomagenesis
The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles
Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Single-cell Co-expression Subnetwork Analysis
IGFBP 1 increases β‐cell regeneration by promoting α‐ to β‐cell transdifferentiation
Aberrant cell cycle regulatory ubiquitin networks in B-cell malignancies
Aberrant B-Cell Activation in Systemic Lupus Erythematosus
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
Mouse models for aberrant NF-kB activation in B-cell development and lymphomagenesis
The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles
Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Single-cell Co-expression Subnetwork Analysis